To further investigate the tumor–host immunity interaction, we examined the tumorigenicity of mouse-derived SCC7 cells treated with LSD1 inhibitors in both immunodeficient nude mice and immunocompetent C3H mice. The gene discussed is KDM1A; the disease is neoplasm.